back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-09-21 15:07 Tx date 2022-09-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,900
+10,000 vol $1.19 each |
71,116 | |
| Filed 2022-03-09 11:22 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
26,750 | |
| Filed 2021-12-29 17:10 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,774 vol |
||
| Filed 2021-12-29 17:10 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,774 vol |
61,116 | |
| Filed 2021-12-29 17:10 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,774 vol |
37,726 | |
| Filed 2021-08-19 15:50 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,461
+1,588 vol $2.18 each |
45,342 | |
| Filed 2021-08-19 15:49 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260.40
+120 vol $2.17 each |
43,754 | |
| Filed 2021-08-19 15:49 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,333
+2,000 vol $2.17 each |
43,634 | |
| Filed 2021-08-19 15:49 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,230
+2,000 vol $2.12 each |
41,634 | |
| Filed 2021-06-28 13:30 Tx date 2021-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,390
+2,600 vol $5.92 each |
39,634 | |
| Filed 2021-06-22 14:50 Tx date 2021-06-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,714
+2,494 vol $5.90 each |
37,034 | |
| Filed 2021-03-08 17:47 Tx date 2021-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
34,540 | |
| Filed 2021-03-08 17:47 Tx date 2021-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
33,040 | |
| Filed 2021-03-08 17:46 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
||
| Filed 2021-03-08 17:46 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
||
| Filed 2021-03-08 16:16 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
||
| Filed 2021-03-08 16:16 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
34,540 | |
| Filed 2021-03-08 16:15 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
||
| Filed 2021-03-08 16:15 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
33,040 | |
| Filed 2020-12-23 12:23 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,531 vol |
31,540 |